Our Team

Laurence Reid, Ph.D., is an entrepreneur, company builder, and biotech executive. He serves as an entrepreneur in residence at Third Rock Ventures, where he focuses on novel drug discovery and development opportunities. Previously, Laurence served as CEO at Decibel Therapeutics, and as CEO of Warp Drive Bio, a small molecule company focused on novel oncology and antibiotic drug discovery based on natural products, until its merger with Revolution Medicines in 2018. Prior to that, he was the senior vice president and chief business officer of Alnylam Pharmaceuticals, where he was responsible for the company’s business development, finance and legal functions. Before coming to Alnylam, Laurence was the chief business officer at Ensemble Discovery, where he led the company’s strategic planning and corporate development efforts. Laurence previously spent ten years at Millennium Pharmaceuticals in a range of general management and business development positions. In addition to his professional interests and his work with the Possible Zone, Laurence is a board advisor to Life Science Cares. He earned his Ph.D. from King’s College, London and his B.A. from Cambridge University.